Algert Global LLC
- SEC CIK
- 0001275218
- Latest filing
- Aug 13, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −713,088−100.0% | Sold out | Holders |
| Q3 2025 | 713,088 | $5.41M | 0.1% | −289,722−28.9% | Reduced | Holders |
| Q2 2025 | 1,002,810 | $8.99M | 0.2% | +42,753+4.5% | Added | Holders |
| Q1 2025 | 960,057 | $7.20M | 0.2% | +234,752+32.4% | Added | Holders |
| Q4 2024 | 725,305 | $5.45M | 0.1% | +209,096+40.5% | Added | Holders |
| Q3 2024 | 516,209 | $3.92M | 0.1% | +163,076+46.2% | Added | Holders |
| Q2 2024 | 353,133 | $2.18M | 0.1% | +55,311+18.6% | Added | Holders |
| Q1 2024 | 297,822 | $1.51M | 0.1% | −38,943−11.6% | Reduced | Holders |
| Q4 2023 | 336,765 | $2.02M | 0.1% | +129,670+62.6% | Added | Holders |
| Q3 2023 | 207,095 | $1.47M | 0.1% | −84,461−29.0% | Reduced | Holders |
| Q2 2023 | 291,556 | $2.05M | 0.1% | +30,570+11.7% | Added | Holders |
| Q1 2023 | 260,986 | $2.18M | 0.1% | +103,042+65.2% | Added | Holders |
| Q4 2022 | 157,944 | $1.81M | 0.1% | +60,817+62.6% | Added | Holders |
| Q3 2022 | 97,127 | $1.22M | 0.1% | +19,139+24.5% | Added | Holders |
| Q2 2022 | 77,988 | $825.0K | 0.1% | +9,874+14.5% | Added | Holders |
| Q1 2022 | 68,114 | $1.11M | 0.1% | +48,058+239.6% | Added | Holders |
| Q4 2021 | 20,056 | $278.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 20,056 | $288.0K | <0.1% | +20,056 | New | Holders |